Yumanity Therapeutics, Inc. (YMTX) Annual Margin Report - Discounting Cash Flows
YMTX
Yumanity Therapeutics, Inc.
YMTX (NASDAQ)

Annual Margin Analysis Report

Margins refer to the ratio between a financial report item and the revenue (Example: Net Income Margin = Net Income / Revenue).

This analysis provides a report of the company's key margins, which could be further used in a valuation model.

Interactive Assumptions

Historical Years

Historical Years

Number of historical years used to render the Chart and Tables.

Margin Analysis (% of Revenue)

Monetary values are in USD

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020
Revenue 6.26 4.34 0 5.44 1.95 9.09 10.49
Revenue Growth Rate 19.31%
-100% 178.6% -78.52% -13.32% 109.8%
Cost of Revenue -0.33 -2.73 0 0.009 0.734 0.669 0
Gross Profit 6.53 7.07 0 5.43 1.22 8.42 10.49
Gross Margin 103.6% 162.9%
99.83% 62.42% 92.64% 100%
Operating Income -15.32 -6.93 -13.53 -15.72 -41.53 -11.09 -3.12
Operating Margin -545.5% -159.8%
-288.9% -2,127% -122% -29.7%
Net Income -21.31 -7.7 -17.13 -14.1 -63.07 -11.96 -13.88
Net Margin -785.9% -177.5%
-259.1% -3,229% -131.6% -132.3%

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020
Revenue 6.26 4.34 0 5.44 1.95 9.09 10.49
Cash From Operating Activities Margin -307.5% -90.92%
-297.9% -974.3% -196.4% 21.89%
Cash From Operating Activities -11.05 -3.94 -11.57 -16.21 -19.03 -17.85 2.3
Free Cash Flow Margin -308.3% -90.92%
-297.9% -978% -196.4% 21.83%
Free Cash Flow -11.06 -3.94 -11.57 -16.21 -19.1 -17.85 2.29
Depreciation and Amortization Margin 1.24% -0.092%
0.165% 3.74% 0.869% 1.51%
Depreciation and Amortization 0.063 -0.004 0 0.009 0.073 0.079 0.158
Capital Expenditure Margin -1.85% 0%
0% -3.64% 0% -0.057%
Capital Expenditure -0.038 0 0 0 -0.071 0 -0.006
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us